4- (1H-indol-3-yl-methylideneaminoxy-pro poxy) -benzioc acid derivatives and related compounds as PAI-1 inhibitors for the treatment of impairment of the fibrinolytic system and of thrombisis

Details for Australian Patent Application No. 2004275823 (hide)

Owner Wyeth

Inventors Butera, John Anthony; Jenkins, Douglas John; Gundersen, Eric Gould; Elokdah, Hassan Mahmoud; Havran, Lisa Marie

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004275823

PCT Pub. Number WO2005/030192

Priority 10/947,846 23.09.04 US; 60/505,801 25.09.03 US

Filing date 24 September 2004

Wipo publication date 7 April 2005

International Classifications

A61K 31/15 (2006.01) - Oximes (CNO)

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

C07C 251/60 (2006.01) Compounds containing nitrogen atoms doubly- bound to a carbon skeleton

C07D 209/14 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

27 April 2006 PCT application entered the National Phase

  PCT publication WO2005/030192 Priority application(s): WO2005/030192

10 July 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004275824-4-(phenyl-ethylideneaminoxy-propoxy) - phenyl-acetic acid derivatives and related compounds as PAI-1 inhibitors for the treatment of impairment of the fibrinolytic system and of thrombosis

2004275821-Methods and products which utilize Nacyl-L-aspartic acid